Business Context and Reporting Period
Company: James Hardie Industries plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of March 2018 (Filed March 23, 2018)
Principal Executive Offices: Dublin 2, Ireland
This filing serves as a notification of specific corporate events and contains forward-looking statements. It does not contain a full set of financial statements for the period.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the period ended March 31, 2018. This document is a procedural filing referencing exhibits rather than a financial results report.
Material Changes and Corporate Events
- Fermacell Acquisition: The filing includes an exhibit (99.1) regarding the acquisition of Fermacell, indicating a significant strategic transaction occurred or was finalized during this period.
- Substantial Shareholding: The filing includes an exhibit (99.2) regarding a Substantial Shareholding Notification dated March 23, 2018.
Guidance, Outlook, and Risks
The document contains an extensive "Forward-Looking Statements" section cautioning investors against undue reliance on future projections. Key risks and uncertainties identified include:
- Asbestos Liabilities: Risks related to the Asbestos Injuries Compensation Fund (AICF), including contribution requirements, potential shortfalls, and currency exchange impacts on recorded liabilities.
- Acquisition Integration: Risks associated with the consummation and integration of the Fermacell acquisition.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, and consumer confidence.
- Legal and Regulatory: Exposure to product liability, environmental, and competition law matters, as well as potential tax charges.
- Operational Risks: Supply and cost of raw materials, weather patterns, and the ability to renew credit facilities.
Investor Verification Checklist
- Verify the final terms and financial impact of the Fermacell acquisition referenced in Exhibit 99.1.
- Review the details of the Substantial Shareholding Notification in Exhibit 99.2 to understand changes in major ownership.
- Consult the most recent Form 20-F or quarterly earnings release for actual revenue, profit, and cash flow figures, as they are absent from this 6-K.
- Monitor updates regarding the Asbestos Injuries Compensation Fund (AICF) and any changes to estimated liabilities.